Catherine C. Fahey

University of North Carolina at Chapel Hill

Also affiliated with UNC Lineberger Comprehensive Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Metastatic Penile Squamous Cell Carcinoma Responsive to Enfortumab Vedotin”.

Metastatic Penile Squamous Cell Carcinoma Responsive to Enfortumab Vedotin

International Journal of Molecular Sciences(2023)10.3390/ijms242216109

N/A

0.470DataRank · unranked

22 citations

Caroline A. Nebhan, Sally J. York, Nancy B. Davis, Paula J. Hurley, Jennifer Gordetsky +2 more

Structure/Function Analysis of Recurrent Mutations in SETD2 Protein Reveals a Critical and Conserved Role for a SET Domain Residue in Maintaining Protein Stability and Histone H3 Lys-36 Trimethylation

UNC Libraries(2020)10.17615/9en3-jz85

N/A

0DataRank · unranked

0 citations

Catherine C. Fahey, Stephen A. Shinsky, Ian J. Davis, Yun-Chen Chiang, W. Kimryn Rathmell +6 more

Polycomb repressor complex 2 suppresses interferon-responsive MHC-II expression in melanoma cells and is associated with anti-PD-1 resistance

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2023-007736

N/A

0DataRank · unranked

29 citations

Brandie C. Taylor, Margaret L. Axelrod, Xiaopeng Sun, Lindsey N. Guerin, Paula I. González-Ericsson +9 more

Triplet Strategies in Metastatic Clear Cell Renal Cell Carcinoma: A Worthy Option in the First-Line Setting?

American Society of Clinical Oncology Educational Book(2023)10.1200/edbk_389650

N/A

0DataRank · unranked

9 citations

Jeffrey Shevach, Ronan Flippot, Laurence Albigès, Naomi B. Haas, Kathryn E. Beckermann +1 more

Immune checkpoint inhibitors: maximizing benefit whilst minimizing toxicity

Expert Review of Anticancer Therapy(2023)10.1080/14737140.2023.2215435

N/A

0DataRank · unranked

5 citations

Thomas J. Gracie, Douglas B. Johnson, Catherine C. Fahey